Brief: Tristel Says US FDA Submission On Schedule For Tristel OPH

Tristel

23/01/2024 07:43

Jan 23 (Reuters) - Tristel PLC  TSTL.L :
    * TRISTEL PLC  - CANADIAN REGULATORY APPROVAL FOR TRISTEL
ULT
    * TRISTEL PLC - US FDA SUBMISSION ON SCHEDULE FOR TRISTEL
OPH
    * TRISTEL PLC -  REVIEW MEETING DATE FOR TRISTEL OPH IS
SCHEDULED
FOR EARLY MARCH 2024
    * TRISTEL PLC -  ANTICIPATES COMPLETING ITS SUBMISSION
SEEKING
510(K) APPROVAL FOR TRISTEL OPH IN SUMMER AND RECEIVING FDA
APPROVAL BY END OF YEAR

Source text for Eikon:  ID:nRSW5203Aa 
Further company coverage:  TSTL.L 

 ((Reuters.Briefs@thomsonreuters.com;))